• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程化STING纳米佐剂用于时空定制的先天免疫刺激和癌症疫苗治疗。

Engineering STING Nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy.

作者信息

Chen Fangmin, Zhang Huijuan, Li Shiqin, Ren Siyuan, Huang Lujia, Cai Zhixiong, Yin Lichen, Zheng Mingyue, Liu Xiaolong, Xu Zhiai, Yu Haijun

机构信息

State Key Laboratory of Chemical Biology & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.

University of Chinese Academy of Sciences, Beijing, 100049, China.

出版信息

Nat Commun. 2025 Jul 1;16(1):5773. doi: 10.1038/s41467-025-60927-7.

DOI:10.1038/s41467-025-60927-7
PMID:40595553
Abstract

Spatiotemporally-tailored activation of dendritic cells (DC) in lymph nodes (LN) remains a critical challenge for effective cancer vaccination therapy. In this study, we show that photo/sonodynamic effect can trigger the nuclear transcription factor-kappa B (NF-κB) and stimulator of interferon genes (STING) pathways activation in DC. We engineers a library of spatiotemporally-tailored STING nanoadjuvants (SNA) by conjugating the photo/sonosensitizer and STING agonist onto the biodegradable polypeptide, and co-assembling with charge-modified polypeptides. The combination of antigen-loaded SNA vaccine (SNVac) with laser irradiation or ultrasound stimulation (namely SNVac-L or SNVac-US) efficiently facilitates DC activation and induces antigen-specific CD8 T cell response in vivo comparing to the free mixture of antigen with STING agonist. We further demonstrate that SNVac-L monotherapy or combination therapy with immune checkpoint blockade (ICB) elicits antitumor immunity to reduce tumor size and prevent tumor relapse in multiple mouse tumor models. This study thus provides a potential translational strategy for spatiotemporally-tailored innate immunity stimulation of DC to potentiate cancer immunotherapy.

摘要

在淋巴结(LN)中对树突状细胞(DC)进行时空定制激活仍然是有效癌症疫苗治疗面临的一项关键挑战。在本研究中,我们表明光/声动力效应可触发DC中的核转录因子-κB(NF-κB)和干扰素基因刺激因子(STING)通路激活。我们通过将光/声敏剂和STING激动剂缀合到可生物降解多肽上,并与电荷修饰多肽共同组装,构建了一个时空定制的STING纳米佐剂(SNA)文库。与抗原与STING激动剂的游离混合物相比,负载抗原的SNA疫苗(SNVac)与激光照射或超声刺激(即SNVac-L或SNVac-US)的组合在体内有效促进DC激活并诱导抗原特异性CD8 T细胞反应。我们进一步证明,SNVac-L单药治疗或与免疫检查点阻断(ICB)联合治疗可引发抗肿瘤免疫,以减小多种小鼠肿瘤模型中的肿瘤大小并预防肿瘤复发。因此,本研究为时空定制DC的固有免疫刺激以增强癌症免疫治疗提供了一种潜在的转化策略。

相似文献

1
Engineering STING Nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy.工程化STING纳米佐剂用于时空定制的先天免疫刺激和癌症疫苗治疗。
Nat Commun. 2025 Jul 1;16(1):5773. doi: 10.1038/s41467-025-60927-7.
2
LASIP: Light-Activated STING Immunotherapeutic Patch: A Multifunctional Microneedle Platform for Combinatorial Mild Hyperthermia with Immunotherapy in Breast Cancer.LASIP:光激活STING免疫治疗贴片:一种用于乳腺癌中联合温和热疗与免疫治疗的多功能微针平台
ACS Appl Mater Interfaces. 2025 Jul 2;17(26):37806-37825. doi: 10.1021/acsami.5c10509. Epub 2025 Jun 17.
3
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.纳米颗粒递送天然免疫激动剂联合衰老诱导剂促进 T 细胞控制胰腺癌。
Sci Transl Med. 2024 Aug 28;16(762):eadj9366. doi: 10.1126/scitranslmed.adj9366.
4
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer.负载cDC1特异性趋化因子XCL1的成熟树突状细胞衍生的细胞外囊泡联合化疗诱导的免疫原性细胞死亡用于去势抵抗性前列腺癌的治疗。
Cancer Immunol Immunother. 2025 Jun 18;74(8):242. doi: 10.1007/s00262-025-04070-8.
5
Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell-Derived Exosomes for Suppressing Tumor Progression and Metastasis.通过工程化树突状细胞衍生的外泌体进行局部区域免疫检查点阻断和淋巴结重塑以抑制肿瘤进展和转移
Adv Sci (Weinh). 2025 Jun;12(23):e2500139. doi: 10.1002/advs.202500139. Epub 2025 Apr 3.
6
Oncolytic immunovirotherapy: finding the tumor antigen needle in the antiviral haystack.溶瘤免疫病毒疗法:在抗病毒的干草堆中寻找肿瘤抗原这根针。
Immunotherapy. 2025 Jun;17(8):585-594. doi: 10.1080/1750743X.2025.2513853. Epub 2025 Jun 6.
7
Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer.利鲁唑通过激活结直肠癌中的cGAS/STING信号增强抗PD-1疗效。
Mol Cancer Ther. 2025 Jan 2;24(1):131-140. doi: 10.1158/1535-7163.MCT-24-0289.
8
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature.胶质母细胞瘤患者自体肿瘤裂解物负载树突状细胞疫苗接种:文献系统评价
Clin Transl Oncol. 2024 Dec 23. doi: 10.1007/s12094-024-03830-9.
9
Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment.用于透明细胞肾细胞癌治疗的生物靶向双重适应性和先天性纳米免疫疗法。
Mol Cancer. 2025 Jun 18;24(1):181. doi: 10.1186/s12943-025-02382-y.
10
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study.在检查点难治性非小细胞肺癌中进行TEIPP疫苗接种:一项首次人体I/II期剂量递增研究。
Nat Commun. 2025 May 28;16(1):4958. doi: 10.1038/s41467-025-60281-8.

本文引用的文献

1
Targeting ROS in cancer: rationale and strategies.靶向癌症中的活性氧:原理与策略。
Nat Rev Drug Discov. 2024 Aug;23(8):583-606. doi: 10.1038/s41573-024-00979-4. Epub 2024 Jul 9.
2
Cancer mRNA vaccines: clinical advances and future opportunities.癌症 mRNA 疫苗:临床进展和未来机遇。
Nat Rev Clin Oncol. 2024 Jul;21(7):489-500. doi: 10.1038/s41571-024-00902-1. Epub 2024 May 17.
3
Precise modulation and use of reactive oxygen species for immunotherapy.精确调控活性氧用于免疫疗法。
Sci Adv. 2024 May 17;10(20):eadl0479. doi: 10.1126/sciadv.adl0479. Epub 2024 May 15.
4
Surgical tumor-derived nanoplatform targets tumor-associated macrophage for personalized postsurgical cancer immunotherapy.手术肿瘤衍生的纳米平台针对肿瘤相关巨噬细胞进行个性化术后癌症免疫治疗。
Sci Adv. 2024 Mar 29;10(13):eadk7955. doi: 10.1126/sciadv.adk7955. Epub 2024 Mar 27.
5
Harnessing innate immune pathways for therapeutic advancement in cancer.利用先天免疫途径推进癌症治疗的进展。
Signal Transduct Target Ther. 2024 Mar 25;9(1):68. doi: 10.1038/s41392-024-01765-9.
6
Therapeutic cancer vaccines: advancements, challenges, and prospects.治疗性癌症疫苗:进展、挑战与展望。
Signal Transduct Target Ther. 2023 Dec 13;8(1):450. doi: 10.1038/s41392-023-01674-3.
7
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity.纳米敏化剂介导的声动力学疗法增效作用及抗肿瘤免疫。
Nat Commun. 2023 Nov 1;14(1):6973. doi: 10.1038/s41467-023-42509-7.
8
A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway.一种靶向 HER2 的抗体-MMAE 偶联物 RC48 通过触发 cGAS-STING 通路使 HER2 阳性结肠癌对免疫治疗敏感。
Cell Death Dis. 2023 Aug 24;14(8):550. doi: 10.1038/s41419-023-06073-8.
9
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates.发现和优化 STING 激动剂平台,应用于抗体药物偶联物。
J Med Chem. 2023 Aug 10;66(15):10715-10733. doi: 10.1021/acs.jmedchem.3c00907. Epub 2023 Jul 24.
10
The landscape of T cell antigens for cancer immunotherapy.癌症免疫治疗的 T 细胞抗原全景。
Nat Cancer. 2023 Jul;4(7):937-954. doi: 10.1038/s43018-023-00588-x. Epub 2023 Jul 6.